Literature DB >> 23096066

Dopaminergic-induced paraphilias associated with impulse control and related disorders in patients with Parkinson disease.

Paolo Solla, Antonino Cannas, Maria Giovanna Marrosu, Francesco Marrosu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23096066     DOI： 10.1007/s00415-012-6691-3

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

2.  Zoophilia and impulse control disorder in a patient with Parkinson disease.

Authors:  Gabriela Raina; Maria Graciela Cersosimo; Federico Micheli
Journal:  J Neurol       Date:  2011-11-05       Impact factor: 4.849

3.  Paraphilia and other disturbed behavior associated with dopamimetic treatment for Parkinson's disease.

Authors:  Olav B Nielssen; Raymond J Cook; Ron Joffe; Linton J Meagher; Paul Silberstein
Journal:  Mov Disord       Date:  2009-05-15       Impact factor: 10.338

4.  Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease.

Authors:  A H Evans; A D Lawrence; J Potts; S Appel; A J Lees
Journal:  Neurology       Date:  2005-11-22       Impact factor: 9.910

5.  Clozapine for dopaminergic-induced paraphilias in Parkinson's disease.

Authors:  H H Fernandez; R Durso
Journal:  Mov Disord       Date:  1998-05       Impact factor: 10.338

6.  Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases.

Authors:  Michael A Shapiro; Yu Ling Chang; Sarah K Munson; Michael S Okun; Hubert H Fernandez
Journal:  Parkinsonism Relat Disord       Date:  2006-05-26       Impact factor: 4.891

7.  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Authors:  V Voon; K Hassan; M Zurowski; M de Souza; T Thomsen; S Fox; A E Lang; J Miyasaki
Journal:  Neurology       Date:  2006-09-06       Impact factor: 9.910

8.  Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.

Authors:  G Giovannoni; J D O'Sullivan; K Turner; A J Manson; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

Review 9.  Current concepts in the pharmacotherapy of paraphilias.

Authors:  Frederico D Garcia; Florence Thibaut
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

10.  Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline.

Authors:  David E Riley
Journal:  Clin Neuropharmacol       Date:  2002 Jul-Aug       Impact factor: 1.592
View more
  5 in total

Review 1.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

Review 2.  Sleep in Parkinson's Disease with Impulse Control Disorder.

Authors:  Michela Figorilli; Patrizia Congiu; Rosa Lecca; Gioia Gioi; Roberto Frau; Monica Puligheddu
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-11       Impact factor: 5.081

Review 3.  Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature.

Authors:  Paolo Solla; Marco Bortolato; Antonino Cannas; Cesare Salvatore Mulas; Francesco Marrosu
Journal:  Mov Disord       Date:  2015-03-11       Impact factor: 10.338

Review 4.  Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease.

Authors:  Atbin Djamshidian; Werner Poewe; Birgit Högl
Journal:  Parkinsons Dis       Date:  2015-11-18

5.  Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice.

Authors:  Yuan-Hao Chen; Vicki Wang; Eagle Yi-Kung Huang; Yu-Ching Chou; Tung-Tai Kuo; Lars Olson; Barry J Hoffer
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.